Evidence map›Paper›PMID 36124173›Full record

ReviewComputational and mathematical methods in medicine2022

Blockchain Powered Vaccine Efficacy for Pharma Sector.

Sharmila, Shashi Bhushan, Pramod Kumar, Anuj Kumar Garg, Shyam Nair

Open access · hybridAbstract readReview
In one paragraph

Review in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

SharmilaDepartment of Electronics & Communication Engineering, Krishna Engineering College, Ghaziabad, India.
Shashi BhushanDepartment of Computer Science, Amity University Punjab, Mohali, India.ORCID https://orcid.org/0000-0003-0667-9627
Pramod KumarDepartment of Computer Science & Engineering, MIET College, Meerut, India.
Anuj Kumar GargDepartment of Blockchain, Zebpay, India.
Shyam NairDepartment of Information Technology, BlueCrest University College, Liberia.ORCID https://orcid.org/0000-0001-8411-1709
University of Liberia · LR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious and contagious diseases exist in humanity for many centuries which causes a curb in the growth of the population. Immunization plays a vital role to prevent mortality and morbidity against infectious diseases. COVID-19 pandemic continues to rage the urgency of developing a vaccine that should ensure the safety, efficacy, swift and fair deployment, implementation, and monitoring of vaccines across the globe. In the present context, the vaccine production to immunization campaign is a critical challenge. Therefore, an effective vaccine supply chain mechanism is required to address issues such as counterfeit vaccines, reduce vaccine wastages, and vaccine record fraud. In this paper, a blockchain-enabled vaccine supply chain is proposed to ensure the correctness, transparency, trust, and immutable log and improve the efficiency of vaccine distribution in the cold chain. The uniqueness of the proposed system is to provide distributed system to verify the reliability and efficacy of the vaccine from production to end beneficiaries' feedback about the vaccine. Our proposed system gives a clear view to the users as well as to the healthcare provider about the vaccination and ensures the anticounterfeit vaccine. The proposed system minimizes counterfeit vaccines and records, provides transparent communication between stakeholders in the supply chain, and improves the security of the vaccine supply chain and immutable feedback system about the vaccine.

Indexed as

BlockchainCOVID-19VaccinesHumansPandemicsReceptor for Advanced Glycation End ProductsReproducibility of ResultsVaccine EfficacyReceptor for Advanced Glycation End ProductsVaccines

Identifiers

PMID36124173
PMCPMC9482494
OpenAlexW4295113703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.